JPH0429680B2 - - Google Patents
Info
- Publication number
- JPH0429680B2 JPH0429680B2 JP58044509A JP4450983A JPH0429680B2 JP H0429680 B2 JPH0429680 B2 JP H0429680B2 JP 58044509 A JP58044509 A JP 58044509A JP 4450983 A JP4450983 A JP 4450983A JP H0429680 B2 JPH0429680 B2 JP H0429680B2
- Authority
- JP
- Japan
- Prior art keywords
- blood coagulation
- factor
- polyethylene glycol
- molecular weight
- coagulation factor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58044509A JPS59172425A (ja) | 1983-03-18 | 1983-03-18 | 新規な血液凝固因子誘導体およびその製造法ならびにそれを含有する血液凝固促進剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP58044509A JPS59172425A (ja) | 1983-03-18 | 1983-03-18 | 新規な血液凝固因子誘導体およびその製造法ならびにそれを含有する血液凝固促進剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59172425A JPS59172425A (ja) | 1984-09-29 |
JPH0429680B2 true JPH0429680B2 (cs) | 1992-05-19 |
Family
ID=12693520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP58044509A Granted JPS59172425A (ja) | 1983-03-18 | 1983-03-18 | 新規な血液凝固因子誘導体およびその製造法ならびにそれを含有する血液凝固促進剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59172425A (cs) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9503380D0 (sv) * | 1995-09-29 | 1995-09-29 | Pharmacia Ab | Protein derivatives |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
WO2004075923A2 (en) | 2003-02-26 | 2004-09-10 | Nektar Therapeutics Al, Corporation | Polymer-factor viii moiety conjugates |
JP4674702B2 (ja) | 2003-04-09 | 2011-04-20 | バイオジェネリクス エージー | グリコペギレ−ション法およびその方法により生成されたタンパク質/ペプチド |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
WO2005055950A2 (en) * | 2003-12-03 | 2005-06-23 | Neose Technologies, Inc. | Glycopegylated factor ix |
JP2008505119A (ja) | 2004-06-30 | 2008-02-21 | ネクター セラピューティクス アラバマ,コーポレイション | 高分子−第ix因子部分の抱合体 |
AU2014280936B2 (en) * | 2004-06-30 | 2016-12-15 | Nektar Therapeutics | Polymer-factor ix moiety conjugates |
EP1771066A2 (en) | 2004-07-13 | 2007-04-11 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1 |
JP5948627B2 (ja) | 2004-10-29 | 2016-07-20 | レイショファーム ゲーエムベーハー | 線維芽細胞成長因子(fgf)のリモデリングと糖質ペグ化 |
LT2371856T (lt) * | 2004-11-12 | 2022-08-25 | Bayer Healthcare Llc | Fviii modifikacija, nukreipta į tam tikrą vietą |
MX2007007877A (es) * | 2004-12-27 | 2007-08-21 | Baxter Int | Conjugados de polimero-factor de von willebrand. |
WO2006074467A2 (en) | 2005-01-10 | 2006-07-13 | Neose Technologies, Inc. | Glycopegylated granulocyte colony stimulating factor |
US20070154992A1 (en) | 2005-04-08 | 2007-07-05 | Neose Technologies, Inc. | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
WO2007056191A2 (en) | 2005-11-03 | 2007-05-18 | Neose Technologies, Inc. | Nucleotide sugar purification using membranes |
EP2049144B8 (en) | 2006-07-21 | 2015-02-18 | ratiopharm GmbH | Glycosylation of peptides via o-linked glycosylation sequences |
EP2054521A4 (en) | 2006-10-03 | 2012-12-19 | Novo Nordisk As | PROCESS FOR CLEANING POLYPEPTIDE CONJUGATES |
HRP20130382T1 (hr) | 2007-04-03 | 2013-05-31 | Biogenerix Ag | Postupci lijeäśenja pomoä†u glikopegiliranog g-csf |
JP5876649B2 (ja) | 2007-06-12 | 2016-03-02 | ラツィオファルム ゲーエムベーハーratiopharm GmbH | ヌクレオチド糖の改良製造法 |
EP2257311B1 (en) | 2008-02-27 | 2014-04-16 | Novo Nordisk A/S | Conjugated factor viii molecules |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5959629A (ja) * | 1982-09-27 | 1984-04-05 | Nippon Chem Res Kk | 効力持続性組成物 |
JPS6042087A (ja) * | 1983-08-19 | 1985-03-06 | Nec Corp | プリンタ |
-
1983
- 1983-03-18 JP JP58044509A patent/JPS59172425A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS59172425A (ja) | 1984-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0429680B2 (cs) | ||
CN1165483B (zh) | 顺氯氨铂和2,2'-二硫代-二(乙磺酸盐)(二巯乙磺酸钠)的组合物 | |
JPH0525470B2 (cs) | ||
JPH0534337B2 (cs) | ||
CN1926155B (zh) | 羟乙基淀粉 | |
JPS5931713A (ja) | オキシカム誘導体含有医薬組成物 | |
KR840001798B1 (ko) | 서방출성 조성물의 제조방법 | |
JPH01500997A (ja) | ヒアルロニダーゼの使用 | |
RU2136291C1 (ru) | Полифункциональный кровезаменитель для лечения кровопотери и шока | |
GB2221907A (en) | Superoxide dismutase composition. | |
JP2003339853A (ja) | 安定な透析用剤 | |
JP2766303B2 (ja) | グリコサミノグリカンで修飾されたスーパーオキシドジスムターゼ及びその製造法 | |
AU725441B2 (en) | An agent for preventing and/or treating multiple organ failure | |
US5439894A (en) | Dextrin derivatives for the treatment of acidic conditions | |
EP1210944A1 (en) | Blood plasma replacement solution | |
POLEC et al. | Protective effect of ascorbic acid, isoascorbic acid and mannitol against tetracycline-induced nephrotoxicity | |
US4271150A (en) | Urokinase preparation for oral administration | |
JPH04225923A (ja) | エリスロポイエチンの水性医薬製剤及びその使用 | |
JPH0215193B2 (cs) | ||
JPS5995221A (ja) | 食細胞機能調節作用を有する医薬組成物 | |
JPH02231076A (ja) | デキストラン修飾スーパーオキシドジスムターゼ | |
JPS6054320A (ja) | 腎疾患治療剤 | |
JPH036790B2 (cs) | ||
JPS59204130A (ja) | 新規プラスミノ−ゲンアクチベ−タ誘導体を含有してなる経口投与薬剤 | |
JPH0568449B2 (cs) |